Search
Twitter-square Facebook-square Linkedin Youtube

IBX Secures Additional Capital — Shareholders Exercise Options

IBX Secures Additional Capital — Shareholders Exercise Options

Imagion Biosystems announces on ASX that it has received a total of $3500 for the exercise of 70,000 Listed Options exercisable at 5 cents, expiring on 26 November 2021.

Please click to review the full announcement at ASX.

Related Articles

Successful Placement of A$3M

October 10, 2024

Imagion Biosystems (ASX: IBX) (Company), is pleased to announce the Company has received $3 million of firm commitments through a highly successful capital raising. The

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Get in touch

About Imagion Biosystems

Imagion Biosystems (IBX) is an innovative medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases.

Contact us

  • info@imagionbio.com
  • Imagion Biosystems, Ltd. Suite 2, Level 11, 385 Bourke Street, Melbourne VIC 3000, Australia
  • AU +61 3 9692 7222
  • Imagion Biosystems, Inc. PO Box 4410 Incline Village, NV 89450 United States

Join our email list

Stay informed about our latest news and developments.

© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance

Twitter-square Facebook-square Linkedin Youtube